Medicines planning
47 results
Applied filters
The licence and supporting evidence for natalizumab biosimilar
14 February 2024One licensed natalizumab biosimilar is available: Tyruko. Learn about the licensed indications and supporting evidence.
SPS Horizon Scanning
18 May 2026Know what medicines are in the pipeline. Understand the strategic and operational challenges for the NHS. Start planning early.
Horizon scanning for ATMPs
13 June 2023Describes what horizon scanning is, how it is performed for the NHS and it's importance for ATMPs.
Costing clinical trials of ATIMPs using the NIHR iCT
11 February 2026Guidance to support and promote consistent pharmacy costing for commercial clinical trials involving ATIMPs.
Annual medicines planning
Our annual Prescribing Outlook output supports planning, implementation and budget planning for medicines every year.
Biosimilars
Regularly updated material to support the introduction of aflibercept, golimumab, ranibizumab, ustekinumab and other biosimilars of interest.
Planning
We support organisations with the planned introduction of medicines. We create annual review products as well as ongoing updates to keep you informed.
National Homecare Medicines Committee (NHMC) Engagement with Manufacturers Advice
4 August 2020Explanation of engagement with the National Homecare Medicines Committee for manufacturers
National Homecare Medicines Committee (NHMC) homecare digital strategy
4 August 2020Find attached the NHMC homecare digital strategy
National Homecare Medicines Committee (NHMC) Homecare Risk Assessment
10 December 2019Find attached the homecare risk assessment spreadsheet to download